News Headlines Article

F.D.A. Panel Votes Against Expanding Use of an Anticoagulant
New York Times

A federal advisory panel narrowly recommended against expanding the use of the Johnson & Johnson drug Xarelto on Wednesday, saying concerns over dangerous bleeding outweighed evidence that the drug helped reduce the risk of blood clots in patients with serious heart problems. Xarelto is an anticoagulant drug that was approved last year to prevent blood clots in patients undergoing knee or hip replacement surgery and for people with a common form of heart arrhythmia called atrial fibrillation.

Commands